1. Alanen, Y. (2011). Schizophrenie – Erscheinungsformen und die bedürfnisangepassteBehandlung. Klett-Cotta.
2. Albert, N., Randers, L., Allott, K., Jensen, H. D., Melau, M., Hjorthøj, C., & Nordentoft, M. (2019). Cognitive functioning following discontinuation of antipsychotic medication. A naturalistic sub-group analysis from the OPUS II trial. Psychological Medicine, 49(7), 1138–1147. https://doi.org/10.1017/S0033291718001836
3. Anthony, W. A. (1993). Recovery from mental illness: The guiding vision of the mental health service system in the 1990s. Psychosocial Rehabilitation Journal, 16(4), 11–23. https://doi.org/10.1037/h0095655
4. Artaloytia, J. F., Arango, C., Lahti, A., Sanz, J., Pascual, A., Cubero, P., Prieto, D., & Palomo, T. (2006). Negative signs and symptoms secondary to antipsychotics: A double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers. The American Journal of Psychiatry, 163(3), 488–493. https://doi.org/10.1176/appi.ajp.163.3.488
5. Awenat, F., Berger, M., Coles, S., Dooley, C., Foster, S., Hanna, J., Hemmingfields, J., Johnstone, L., Nadirshaw, Z., Wainwright, T., & Whomsley, S. (2013). Classification of behaviour and experience in relation to functional psychiatric diagnoses: Time for a paradigm shift DCP Position Statement. The British Psychological Society. Puedeleerseen https://cutt.ly/rUzrlTc